Seanergy Dermatology Ltd.

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.

Phase 1

Conditions: Atopic Dermatitis

Interventions: Drug: SNG100
Drug: Hydrocortisone Acetate 1% Cream
Drug: Mometasone Furoate

First Posted Date: 2020-11-04

Last Posted Date: 2020-11-04

Lead Sponsor: Seanergy Dermatology Ltd.

Target Recruit Count: 66

Registration Number: NCT04615962

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy